Skip to main content

ICD-10-CM R63.8, Other symptoms and signs concerning food and fluid intake | No Prior Auth

Backwork Sign up free

Ask Backwork/R63.8

`R63.8`, Other symptoms and signs concerning food and fluid intake

ICD-10-CM

Prior Authorization

No Prior Auth Required

No active coverage policies found for this code (low confidence)

Documentation Required

Medical records must document the medical necessity of the serum magnesium test, including the signs, symptoms, and/or diagnosis that prompted the test.
Laboratories must maintain the physician's order for the serum magnesium test in their records.
Medical records must contain the serum magnesium lab test results.
When requesting individual consideration through written redetermination, providers must include all relevant medical records and supporting literature.

Key Coverage Criteria

Persons with discrepant celiac-specific serology and histology;
Serological testing of IgA anti-human tissue transglutaminase (TTG) antibodies, IgG and IgA deamidated gliadin antibodies (DGP), and IgA anti-endomysial antibodies (EMA) for any of the following indications:
As a preliminary diagnostic test for persons with symptoms suggestive of celiac disease;
To monitor response to a gluten-free diet;
To screen first-degree relatives of individuals with celiac disease;
To screen persons with type 1 diabetes for celiac disease.

5 Active Policies

ANTHEM-LAB.00027, Selected Blood, Serum and Cellular Allergy and Toxicity Tests

ANTHEM-CG-LAB-21, Serum Iron Testing

ANTHEM-CG-LAB-20, Thyroid Testing

AETNA-CPB-0561, Celiac Disease Laboratory Testing

A57189, Billing and Coding: Serum Magnesium

Related Codes

K90.0(5 policies)R53.83(3 policies)E08.00(3 policies)E64.0(3 policies)E13.9(3 policies)R63.0(3 policies)D50.0(2 policies)D09.9(2 policies)

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about R63.8 Sign up free

For redetermination, providers must submit at minimum two (2) Phase II studies or one (1) Phase III study to support the request.

Documentation of symptoms suggestive of celiac disease when serologic testing is performed (for use as preliminary diagnostic test).